BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1011 related articles for article (PubMed ID: 17320661)

  • 1. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract.
    Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K
    Urology; 2007 Feb; 69(2):265-9. PubMed ID: 17320661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract.
    Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K
    J Urol; 2007 Oct; 178(4 Pt 1):1212-7; discussion 1217. PubMed ID: 17698147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.
    Matin SF; Sfakianos JP; Espiritu PN; Coleman JA; Spiess PE
    J Urol; 2015 Dec; 194(6):1567-74. PubMed ID: 26094807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of lymphadenectomy in the treatment of transitional cell carcinoma of the upper urinary tract.
    Komatsu H; Tanabe N; Kubodera S; Maezawa H; Ueno A
    J Urol; 1997 May; 157(5):1622-4. PubMed ID: 9112490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer.
    Roscigno M; Shariat SF; Freschi M; Margulis V; Karakiewizc P; Suardi N; Remzi M; Zigeuner R; Bolenz C; Kikuchi E; Weizer A; Bensalah K; Sagalowsky A; Koppie TM; Raman J; Fernández M; Ströbel P; Kabbani W; Langner C; Wheat J; Guo CC; Kassouf W; Haitel A; Wood CG; Montorsi F
    Urology; 2009 Nov; 74(5):1070-4. PubMed ID: 19883824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes.
    Abe T; Shinohara N; Muranaka M; Sazawa A; Maruyama S; Osawa T; Harabayashi T; Kubota K; Matsuno Y; Shibata T; Toyada Y; Shinno Y; Minami K; Sakashita S; Kumagai A; Takada N; Togashi M; Sano H; Mori T; Nonomura K
    Eur J Surg Oncol; 2010 Nov; 36(11):1085-91. PubMed ID: 20832972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Post-operative recurrence patterns of urothelial tumors in the upper urinary tract: comparison between renal pelvic and ureteral tumors].
    Sengiku A; Nishiyama H; Shimizu T; Watabe J; Soda T; Kamba T; Yoshimura K; Kanematsu A; Nakamura E; Kamoto T; Ogawa O
    Hinyokika Kiyo; 2008 Nov; 54(11):703-9. PubMed ID: 19068723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Roscigno M; Shariat SF; Margulis V; Karakiewicz P; Remzi M; Kikuchi E; Langner C; Lotan Y; Weizer A; Bensalah K; Raman JD; Bolenz C; Guo CC; Wood CG; Zigeuner R; Wheat J; Kabbani W; Koppie TM; Ng CK; Suardi N; Bertini R; Fernández MI; Mikami S; Isida M; Michel MS; Montorsi F
    J Urol; 2009 Jun; 181(6):2482-9. PubMed ID: 19371878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy.
    Xylinas E; Rink M; Margulis V; Faison T; Comploj E; Novara G; Raman JD; Lotan Y; Guillonneau B; Weizer A; Pycha A; Scherr DS; Seitz C; Sun M; Trinh QD; Karakiewicz PI; Montorsi F; Zerbib M; Gönen M; Shariat SF;
    J Urol; 2013 Feb; 189(2):468-73. PubMed ID: 23253960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma.
    Lughezzani G; Jeldres C; Isbarn H; Shariat SF; Sun M; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Jan; 75(1):118-24. PubMed ID: 19864000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy.
    Hurel S; Rouprêt M; Ouzzane A; Rozet F; Xylinas E; Zerbib M; Berod AA; Ruffion A; Adam E; Cussenot O; Houlgatte A; Phé V; Nouhaud FX; Bensadoun H; Delage F; Guillotreau J; Guy L; Karsenty G; De La Taille A; Colin P;
    BJU Int; 2013 Jun; 111(8):1199-207. PubMed ID: 23650914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The rule of lymph node metastasis of adenosquamous carcinoma of the lung].
    Li J; Zhang DC; He J; Liu XY; Mu JW; Zhang LZ
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):524-7. PubMed ID: 19950701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?
    Maulard-Durdux C; Dufour B; Hennequin C; Chrétien Y; Vignes B; Droz D; Delanian S; Housset M
    J Urol; 1996 Jan; 155(1):115-7. PubMed ID: 7490805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan.
    Kamihira O; Hattori R; Yamaguchi A; Kawa G; Ogawa O; Habuchi T; Kawauchi A; Uozumi J; Yokoi S; Tsujihata M; Hasui Y; Miyakoda K; Tada H; Ono Y; Naito S
    Eur Urol; 2009 Jun; 55(6):1397-407. PubMed ID: 19299072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic spread among women with primary peritoneal carcinoma.
    Eltabbakh GH; Mount SL
    J Surg Oncol; 2002 Nov; 81(3):126-31. PubMed ID: 12407724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation of the pathological nodal staging score in upper tract urothelial carcinoma: A population-based study.
    Xylinas E; Kluth L; Rieken M; Rouprêt M; Al Hussein Al Awamlh B; Clozel T; Sun M; Karakiewicz PI; Gonen M; Shariat SF
    Urol Oncol; 2017 Jan; 35(1):33.e21-33.e26. PubMed ID: 27816402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early results of chemotherapy with retroperitoneal lymph node dissection for isolated retroperitoneal recurrence of upper urinary tract urothelial carcinoma after nephroureterectomy.
    Childs MA; Wood CG; Spiess PE; Debiane LG; Hernandez M; Matin SF; Millikan RE; Siefker-Radtkie A; Scott SM; Pisters LL
    Can J Urol; 2010 Jun; 17(3):5184-9. PubMed ID: 20566011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of lymphadenectomy in upper tract urothelial carcinoma.
    Weight CJ; Gettman MT
    Urol Clin North Am; 2011 Nov; 38(4):429-37, vi. PubMed ID: 22045174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.